Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Erik Ranheim
University of Wisconsin Madison, Department: Pediatrics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Unity Point Healthcare
Payment for services (e.g., consulting fees, honoraria, paid authorship)
An outside activity has a nexus with an individual's research activities if the outside activity arises from, relies upon or is related to the academic expertise that qualifies that individual to participate in federally funded research or human subjects research.
The Institution has reasonably determined that the significant financial interest could directly and significantly affect the design, conduct, or reporting of the PHS-funded research and so requires management.
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
Ideal cancer therapy should be tumor-specific, eradicate primary tumors and metastases, prevent recurrence and have no side effects; immunotherapy (activation of patient's immune cells) has the potential to fulfill these requirements. Our researc team has tested combinations of immunotherapies in mice, and has moved the most effective approaches into clinical treatment, benefitting some patients, including children with neuroblastoma. We are now testing new combinations of immunotherapies that should each act in different ways, but be more effective when combined; our goal is to identify and refine combinations of 'off the shelf' immunotherapies that can effectively eliminate cancer and prolong life, for cancer patients worldwide.
Filed on August 18, 2015.
Tell us what you know about Erik Ranheim's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.